# A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

> **NCT02064010** · PHASE2 · WITHDRAWN · sponsor: **Synchroneuron Inc.**

## Conditions studied

- Drug-induced Tardive Dyskinesia

## Interventions

- **DRUG:** SNC-102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02064010
- **Lead sponsor:** Synchroneuron Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2015-01
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding terminated; company closed
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064010, "A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02064010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*